IT1395137B1 - Nuovi peptidi antipatogeni - Google Patents

Nuovi peptidi antipatogeni

Info

Publication number
IT1395137B1
IT1395137B1 ITMI2009A001425A ITMI20091425A IT1395137B1 IT 1395137 B1 IT1395137 B1 IT 1395137B1 IT MI2009A001425 A ITMI2009A001425 A IT MI2009A001425A IT MI20091425 A ITMI20091425 A IT MI20091425A IT 1395137 B1 IT1395137 B1 IT 1395137B1
Authority
IT
Italy
Prior art keywords
antipatogenic
peptides
new
new antipatogenic
antipatogenic peptides
Prior art date
Application number
ITMI2009A001425A
Other languages
English (en)
Italian (it)
Inventor
Santo Landolfo
Andrea Giuliani
Giorgio Gribaudo
Lorena Pizzuto
Giovanna Pirri
Davide Gibellini
David Lembo
Original Assignee
Spider Biotech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spider Biotech S R L filed Critical Spider Biotech S R L
Priority to ITMI2009A001425A priority Critical patent/IT1395137B1/it
Priority to CA2768748A priority patent/CA2768748A1/en
Priority to EP10739940.4A priority patent/EP2462155B1/en
Priority to AU2010280682A priority patent/AU2010280682A1/en
Priority to JP2012523341A priority patent/JP2013501030A/ja
Priority to PCT/EP2010/061424 priority patent/WO2011015628A1/en
Priority to US13/387,154 priority patent/US8877738B2/en
Priority to CN2010800283316A priority patent/CN102574893A/zh
Publication of ITMI20091425A1 publication Critical patent/ITMI20091425A1/it
Application granted granted Critical
Publication of IT1395137B1 publication Critical patent/IT1395137B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ITMI2009A001425A 2009-08-05 2009-08-05 Nuovi peptidi antipatogeni IT1395137B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITMI2009A001425A IT1395137B1 (it) 2009-08-05 2009-08-05 Nuovi peptidi antipatogeni
CA2768748A CA2768748A1 (en) 2009-08-05 2010-08-05 Novel antipathogenic peptides
EP10739940.4A EP2462155B1 (en) 2009-08-05 2010-08-05 Novel antipathogenic peptides
AU2010280682A AU2010280682A1 (en) 2009-08-05 2010-08-05 Novel antipathogenic peptides
JP2012523341A JP2013501030A (ja) 2009-08-05 2010-08-05 新規抗病原性ペプチド
PCT/EP2010/061424 WO2011015628A1 (en) 2009-08-05 2010-08-05 Novel antipathogenic peptides
US13/387,154 US8877738B2 (en) 2009-08-05 2010-08-05 Antipathogenic peptides
CN2010800283316A CN102574893A (zh) 2009-08-05 2010-08-05 新的抗致病肽

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001425A IT1395137B1 (it) 2009-08-05 2009-08-05 Nuovi peptidi antipatogeni

Publications (2)

Publication Number Publication Date
ITMI20091425A1 ITMI20091425A1 (it) 2011-02-06
IT1395137B1 true IT1395137B1 (it) 2012-09-05

Family

ID=42046263

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001425A IT1395137B1 (it) 2009-08-05 2009-08-05 Nuovi peptidi antipatogeni

Country Status (8)

Country Link
US (1) US8877738B2 (enExample)
EP (1) EP2462155B1 (enExample)
JP (1) JP2013501030A (enExample)
CN (1) CN102574893A (enExample)
AU (1) AU2010280682A1 (enExample)
CA (1) CA2768748A1 (enExample)
IT (1) IT1395137B1 (enExample)
WO (1) WO2011015628A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2538335T3 (es) 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
US10702572B2 (en) * 2015-07-28 2020-07-07 Carnegie Mellon University Methods and compounds to suppress viral genome release and packaging
RU2655763C2 (ru) * 2016-10-24 2018-05-29 Общество С Ограниченной Ответственностью "Айвикс" Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN120349386B (zh) * 2025-04-29 2025-11-28 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 人工合成多肽p2及其在抗疱疹病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1252808A (zh) * 1997-02-20 2000-05-10 耶达研究及发展有限公司 抗病原合成肽及包含该肽类的组合物
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US20090087878A9 (en) * 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
AUPR412801A0 (en) 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
EP1572079A4 (en) * 2002-03-29 2006-09-06 Centocor Inc MAMMAL-CDR MIMETIC BODIES, COMPOSITIONS, PROCESSES AND APPLICATION PURPOSES
WO2005081687A2 (en) * 2003-09-30 2005-09-09 Centocor, Inc. Human hinge core mimetibodies, compositions, methods and uses
TW200526637A (en) * 2003-09-30 2005-08-16 Janssen Pharmaceutica Nv Benzoimidazole compounds
JP2008505928A (ja) * 2004-07-08 2008-02-28 アムジェン　インコーポレーテッド 治療用ペプチド
EP1778271B1 (en) 2004-08-18 2008-10-22 IPF Pharmaceuticals GmbH Peptides for the treatment of herpes virus infections
EP2061886B1 (en) * 2006-08-21 2014-05-07 The University Of British Columbia Small cationic immunomodulatory peptides
US20110171233A1 (en) * 2007-08-22 2011-07-14 Ribovax Biotechnologies S.A. Antibodies Against Human Cytomegalovirus (HCMV)

Also Published As

Publication number Publication date
EP2462155B1 (en) 2015-05-27
AU2010280682A1 (en) 2012-01-19
CA2768748A1 (en) 2011-02-10
WO2011015628A1 (en) 2011-02-10
US8877738B2 (en) 2014-11-04
EP2462155A1 (en) 2012-06-13
JP2013501030A (ja) 2013-01-10
CN102574893A (zh) 2012-07-11
US20120121623A1 (en) 2012-05-17
ITMI20091425A1 (it) 2011-02-06

Similar Documents

Publication Publication Date Title
NL301140I2 (nl) duvelisib
HUE036081T2 (hu) Mirac proteinek
DK2414015T3 (da) Laryngoskopsystem
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
EP2469625A4 (en) OMNIBUS BAR
EP2445547A4 (en) CATHETERISM SYSTEM
EP2491340A4 (en) TELEMETRY PHOTOGRAPHIC APPARATUS
EP2407456A4 (en) CARBAZOLE ESTER-OXIME PHOTOINITIATOR
EP2440486A4 (en) CABLE RETRACTION SYSTEM
EP2433940A4 (en) SPIROIMIDAZOLONE DERIVATIVE
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1008827A2 (pt) deisobutenizador
BR112012000657A2 (pt) novos azabicilohexanos
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1010661A2 (pt) peptídeo
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
EP2402744A4 (en) CARBURATION DETECTION METHOD
BRPI1008070A2 (pt) tricianoboratos
EP2446176A4 (en) CYLINDER SEAL